Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Free Cash Flow (2016 - 2025)

Palisade Bio (PALI) has disclosed Free Cash Flow for 16 consecutive years, with -$3.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Free Cash Flow fell 13.41% to -$3.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$10.1 million, a 19.7% increase, with the full-year FY2024 number at -$12.2 million, down 9.48% from a year prior.
  • Free Cash Flow was -$3.6 million for Q3 2025 at Palisade Bio, down from -$1.8 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$1.2 million in Q1 2021 to a low of -$3.8 million in Q1 2022.
  • A 5-year average of -$2.9 million and a median of -$3.1 million in 2022 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: plummeted 201.12% in 2022, then skyrocketed 48.07% in 2025.
  • Palisade Bio's Free Cash Flow stood at -$1.2 million in 2021, then crashed by 165.28% to -$3.3 million in 2022, then grew by 17.19% to -$2.7 million in 2023, then increased by 13.29% to -$2.4 million in 2024, then tumbled by 49.22% to -$3.6 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Free Cash Flow are -$3.6 million (Q3 2025), -$1.8 million (Q2 2025), and -$2.3 million (Q1 2025).